PPARgamma: The Portrait of a Target Ally to Cancer Chemopreventive Agents.
Peroxisome proliferator-activated receptor-gamma (PPARgamma), one of three ligand-activated transcription factors named PPAR, has been identified as a molecular target for cancer chemopreventive agents. PPARgamma was initially understood as a regulator of adipocyte differentiation and glucose homeostasis while later on, it became evident that it is also involved in cell differentiation, apoptosis, and angiogenesis, biological processes which are deregulated in cancer. It is now established that PPARgamma ligands can induce cell differentiation and yield early antineoplastic effects in several tumor types. Moreover, several bioactive natural products with cancer protecting potential are shown to operate through activation of PPARgamma. Overall, PPARgamma appears to be a prevalent target ally to cancer chemopreventive agents and therefore pursuing research in this area is of great relevance.
Sainis
Ioannis
I
Department of Biological Applications and Technologies, University of Ioannina, Ioannina 45110, Greece.
Vareli
Katerina
K
Karavasilis
Vasilios
V
Briasoulis
Evangelos
E
Cancer Biol Ther. 2005 Jul;4(7):687-93
16082179
J Clin Oncol. 2005 May 10;23(14):3186-97
15886305
Mol Cells. 2007 Oct 31;24(2):167-76
17978568
J Biol Chem. 1997 Feb 21;272(8):5128-32
9030579
Nature. 2000 May 25;405(6785):421-4
10839530
FEBS Lett. 2001 May 4;496(1):12-8
11343698
Nat Med. 1998 Sep;4(9):1046-52
9734398
Mol Cancer Ther. 2004 Aug;3(8):1011-20
15299084
Clin Cancer Res. 1997 Jan;3(1):25-30
9815533
Mol Pharmacol. 2007 Jun;71(6):1715-20
17412838
Oncogene. 2006 Feb 23;25(8):1225-41
16288226
J Endocrinol. 1999 Sep;162(3):331-40
10467224
Am J Respir Cell Mol Biol. 2005 Apr;32(4):350-9
15677767
Cancer Res. 2005 Feb 15;65(4):1561-9
15735046
PPAR Res. 2008;2008:431763
18464916
Food Chem Toxicol. 1996 Mar;34(3):313-6
8621114
Cancer Sci. 2003 Nov;94(11):960-4
14611672
Cell. 1992 Mar 6;68(5):879-87
1312391
Cancer Res. 2003 Sep 15;63(18):5926-39
14522919
Cancer Biol Ther. 2007 Jan;6(1):99-106
17172826
J Biol Chem. 2002 Feb 8;277(6):4062-8
11733495
Cancer J. 2002 Sep-Oct;8(5):395-9
12416897
Cell Cycle. 2007 Jul 1;6(13):1539-48
17611413
J Biol Chem. 1998 Nov 20;273(47):31108-12
9813012
Endocr Rev. 1999 Oct;20(5):649-88
10529898
Carcinogenesis. 2003 Nov;24(11):1717-22
12949056
Mol Endocrinol. 2000 Dec;14(12):1962-75
11117527
Science. 2000 Aug 25;289(5483):1357-60
10958784
Biochem J. 2002 Sep 15;366(Pt 3):767-75
12059785
Annu Rev Pharmacol Toxicol. 1989;29:145-63
2658768
Prog Lipid Res. 2006 Mar;45(2):120-59
16476485
Nature. 1998 Sep 10;395(6698):137-43
9744270
Int J Cancer. 2004 Dec 20;112(6):909-19
15316938
Cancer Res. 2005 May 15;65(10):4181-90
15899809
Cancer Causes Control. 2008 Oct;19(8):813-8
18350370
Int J Cancer. 2007 Jul 15;121(2):248-56
17354222
Eur J Pharmacol. 2007 Mar 15;559(1):1-13
17258704
Nature. 1992 Aug 27;358(6389):771-4
1324435
J Thorac Oncol. 2007 Nov;2(11):989-92
17975488
Cancer Res. 2008 Apr 15;68(8):2912-9
18413760
Lancet Oncol. 2003 Nov;4(11):659-69
14602246
J Biol Chem. 2006 May 26;281(21):14700-10
16574647
Cell. 2005 Dec 16;123(6):993-9
16360030
Mol Pharmacol. 2006 Nov;70(5):1524-33
16887936
Science. 2001 Nov 30;294(5548):1866-70
11729302
Cancer Res. 2000 Feb 15;60(4):1129-38
10706135
Neoplasia. 2005 Mar;7(3):294-301
15799829
Food Chem Toxicol. 2007 May;45(5):708-15
17306913
Oncogene. 2003 Jun 19;22(25):3888-900
12813462
Eur J Cancer. 2007 Nov;43(17):2590-601
17911009
Int J Oncol. 2001 Nov;19(5):929-39
11604990
Science. 1996 Dec 20;274(5295):2100-3
8953045
Biochim Biophys Acta. 2007 Aug;1771(8):952-60
17560826
Int J Cancer. 2006 Feb 1;118(3):773-9
16094629
J Biol Chem. 1997 Jul 25;272(30):18779-89
9228052
Biochem Biophys Res Commun. 2000 Apr 13;270(2):400-5
10753637
Nat Med. 1998 Sep;4(9):1058-61
9734400
Nutr Cancer. 2007;59(2):169-75
18001211
J Biol Chem. 2003 Jan 10;278(2):962-7
12421816
Mol Cancer Ther. 2007 May;6(5):1588-98
17513608
N Engl J Med. 2007 Jun 14;356(24):2457-71
17517853
Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1213-21
14652284
Cancer Epidemiol Biomarkers Prev. 2004 Nov;13(11 Pt 1):1704-9
15533896
PPAR Res. 2007;2007:93416
17389773
Mol Cell. 1998 Feb;1(3):465-70
9660931
Oncogene. 2004 Jan 8;23(1):100-8
14712215
Clin Cancer Res. 2007 Jan 1;13(1):246-52
17200362
Int J Oncol. 2000 Dec;17(6):1157-64
11078801
Cancer Res. 2006 Mar 15;66(6):3222-9
16540674
J Agric Food Chem. 2006 Feb 8;54(3):810-4
16448187
Breast Cancer Res Treat. 2003 Jun;79(3):391-7
12846423
Clin Cancer Res. 2006 Mar 15;12(6):1828-38
16551868
Biochem Biophys Res Commun. 1997 Apr 28;233(3):756-9
9168928
J Clin Invest. 2002 Oct;110(7):923-32
12370270
J Nutr Biochem. 2005 Jun;16(6):321-30
15936643
N Engl J Med. 1998 Oct 1;339(14):953-9
9753710
Gut. 2007 Nov;56(11):1557-63
17604322
Genes Dev. 1994 May 15;8(10):1224-34
7926726
Annu Rev Med. 2002;53:409-35
11818483
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13771-6
12370429
Int J Cancer. 2007 Sep 1;121(5):1103-14
17487840
Chest. 2007 Sep;132(3 Suppl):69S-77S
17873161
J Biol Chem. 1997 Mar 21;272(12):8071-6
9065481
J Natl Cancer Inst. 2000 Mar 1;92(5):418-23
10699072
Int J Cancer. 2006 Feb 1;118(3):593-9
16094650
Nature. 1990 Oct 18;347(6294):645-50
2129546
Cancer Res. 2000 Oct 1;60(19):5494-8
11034093
Clin Cancer Res. 2001 May;7(5):1452-8
11350917
Am J Epidemiol. 2001 Jun 15;153(12):1142-7
11415946
Nat Rev Cancer. 2004 Jan;4(1):61-70
14708026
Nutr Cancer. 2007;59(1):82-91
17927506
Eur J Cancer. 2007 Jul;43(11):1755-63
17582756
J Clin Oncol. 2007 Apr 20;25(12):1476-81
17442990
FEBS Lett. 1998 Oct 30;438(1-2):55-60
9821958
Cancer Res. 2000 Oct 1;60(19):5558-64
11034103
Annu Rev Pharmacol Toxicol. 2000;40:491-518
10836145
Biochim Biophys Acta. 2004 Nov 18;1675(1-3):113-9
15535974
J Biol Chem. 2003 Feb 28;278(9):7431-8
12468551
Lung Cancer. 2006 Mar;51(3):297-301
16386327
Carcinogenesis. 2008 Apr;29(4):797-806
18174233
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10990-5
10984506
Int J Gynecol Cancer. 2008 Mar-Apr;18(2):329-38
18334011
J Nat Prod. 2006 Nov;69(11):1611-3
17125231
Eur J Cancer Prev. 2002 Aug;11(4):351-8
12195161
Life Sci. 2002 Feb 15;70(13):1565-75
11895107
Thyroid. 2005 Jun;15(6):594-9
16029127
Br J Cancer. 2003 Oct 20;89(8):1409-12
14562008
Nutr Cancer. 2004;48(2):160-70
15231450
Nat Rev Drug Discov. 2007 Apr;6(4):273-86
17396134
J Mol Endocrinol. 1993 Aug;11(1):37-47
8240670
Mol Cell Biol. 2007 Feb;27(3):803-17
17101779
Med Hypotheses. 2008;70(2):419-23
17548167
Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):237-41
8990192
Cancer Res. 2004 May 15;64(10):3701-13
15150131
Clin Cancer Res. 2004 Mar 15;10(6):1911-9
15041706
Expert Opin Investig Drugs. 2006 Sep;15(9):1039-49
16916271
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8806-11
9671760
Nature. 1998 Nov 26;396(6709):377-80
9845075
Am J Pathol. 2002 Nov;161(5):1647-56
12414512
Nutr Cancer. 2007;59(2):163-8
18001210
Clin Cancer Res. 2007 Jul 15;13(14):4042-5
17634527
Carcinogenesis. 2007 Nov;28(11):2337-46
17724373
Carcinogenesis. 2004 Sep;25(9):1747-55
15073042
Mol Pharmacol. 2002 Nov;62(5):1207-14
12391285
Int J Cancer. 2006 Nov 15;119(10):2339-46
16858678
Lancet Oncol. 2005 Nov;6(11):899-904
16257798
Mol Cancer Res. 2004 Oct;2(10):541-50
15498928
Toxicol Lett. 1998 Dec 28;102-103:85-90
10022237
J Med Food. 2004 Fall;7(3):267-73
15383218
Cancer Causes Control. 1998 Jan;9(1):89-97
9486468